Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-12

Clinical Trial Update: Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy [NA]

View source ↗

Summary

A clinical trial update evaluating venetoclax in combination with intensive therapy for acute myeloid leukemia patients who show low early peripheral blast clea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venetoclax (venetoclax)

Snippet

Sponsor: Affiliated Hospital of Nantong University | Conditions: Leukemia, Leukemia, Myeloid | NA | Status: RECRUITING